Cargando…
Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled Trial
Objective. To ascertain the efficacy and safety of Ganji Formulation (GF) for patients with Hepatocellular carcinoma (HCC) who had undergone surgery. Materials and Methods. A total of 262 HCC patients who had undergone liver resection, local ablation, or transcatheter arterial chemoembolization (TAC...
Autores principales: | Zhang, Jing-Hao, Zheng, Chao, Zhu, Xiao-Jun, Zhang, Xin, Hou, Zhi-Jun, Zhou, Zhen-Hua, Wang, Yu-Qing, Wang, Kai-Xia, Yu, Zhuo, Li, Man, Gao, Yue-Qiu, Sun, Xue-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607716/ https://www.ncbi.nlm.nih.gov/pubmed/31320916 http://dx.doi.org/10.1155/2019/9492034 |
Ejemplares similares
-
Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology
por: Yang, Miaolun, et al.
Publicado: (2023) -
Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy
por: Zhao, Xuran, et al.
Publicado: (2020) -
The use of drugs in patients who have undergone bariatric surgery
por: Geraldo, Mariana de Sousa Prado, et al.
Publicado: (2014) -
Effect of COVID-19 Pandemic on Patients Who Have Undergone Liver Transplantation Because of Hepatocellular Carcinoma
por: Akbulut, Sami, et al.
Publicado: (2023) -
Risk of Malnutrition in Adults Who Have Undergone Sleeve Gastrectomy: A Retrospective Study
por: Liao, Wan-Chun, et al.
Publicado: (2023)